Lucibelzu

Lucibelzu uses and dosage

Lucibelzu (Belzutifan), generic WELIREG is a prescription medicine used to treat adult patients with von Hippel-Lindau (VHL) disease. Belzutifan is indicated for use in patients who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), and who do not require immediate surgical intervention. Lucibelzu manufactured by Lucius Pharmaceutical Co. Ltd. in Laos. Belzutifan has to take orally once a day with or without food as directed by patient’s doctor.

Lucibelzu side effects

The most common side effects of Belzutifan are: Nausea, vomiting, constipation, abdominal pain, muscle/joint pain, dizziness, or headache.

Originator brand

WELIREG by MERCK SHARP DOHME

Made by

Lucius Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.